Document is current
Any future updates will be listed below
-
Authors
Liu, Yi
Whitfield, Troy W. https://orcid.org/0000-0002-2026-4201
Bell, George W. https://orcid.org/0000-0001-6826-2507
Guo, Ruisi
Flamier, Anthony
Young, Richard A. https://orcid.org/0000-0001-8855-8647
Jaenisch, Rudolf https://orcid.org/0000-0002-2540-7099
- License Information
-
More Information
Article History
Accepted: 23 April 2025
First Online: 13 May 2025
Competing interests
: R.J. is an adviser and co-founder of Fate Therapeutics and Fulcrum Therapeutics. A.F. is a co-founder and shareholder of StemAxon. R.A.Y. is a founder and shareholder of Syros Pharmaceuticals, Camp4 Therapeutics, Omega Therapeutics, Dewpoint Therapeutics and Paratus Sciences. All other authors declare no competing interests.
